India Tightens Restrictions on E-Cigarettes Despite Easy Availability

May.24.2023
India Tightens Restrictions on E-Cigarettes Despite Easy Availability
India strengthens enforcement of ban on e-cigarettes to combat ease of access and use by minors.

According to a report from The Hindu, despite India's 2019 ban on electronic cigarettes, they are still easily accessible for purchase online and in tobacco shops. Recently, the Indian Ministry of Health issued a notice demanding stricter enforcement of the law that prohibits the production, sale, and promotion of electronic cigarettes.


Additional restrictions imposed.


The "Prohibition of Electronic Cigarettes (Production, Manufacture, Import, Export, Transport, Sale, Distribution, Storage and Advertising) Act" came into effect in India in 2019. The Health Ministry has directed all manufacturers, producers, importers and other related companies not to directly or indirectly produce, manufacture, import, export, transport, sell, distribute or store electronic cigarettes, whether it is a complete product or any of its parts.


In a recent notice issued by the Ministry of Health, all companies involved in the electronic cigarette industry are prohibited from advertising or participating in any direct or indirect promotion of electronic cigarettes.


The department added in its announcement that violations of the production, manufacture, import, export, transportation, sale (including online sales), distribution, storage, and advertising of electronic cigarettes are identifiable and will be punished according to the legal provisions of this legislation.


The issue of underage usage is a serious problem.


According to Binoy Mathew, manager of the Voluntary Health Association of India, although the Indian government banned e-cigarettes in 2019, they are still easily available for purchase in tobacco shops and online, and are being sold to minors under the age of 18.


He welcomes the government's release of notifications to the public to strictly enforce and implement the law.


Despite the fact that the sale of electronic cigarettes is facing heavy penalties and imprisonment, they are widely available through various channels including tobacco merchants, regular stores, and online suppliers. Underage individuals, including students, have extensively used electronic cigarettes.


Ranjit Singh, a lawyer at the Supreme Court of India, has stated during his practice that:


The ease with which banned products are being obtained in the Indian market is a cause for concern. Electronic cigarettes and similar products have enticing flavors that might lead the younger generation to develop nicotine addiction.


Strengthening the commitment to "ban electronic cigarettes


The announcement released by the Ministry of Health has increased public awareness of the ban on electronic cigarettes and provided detailed explanations of the provisions of the 2019 law banning electronic cigarettes. It has also strengthened the Indian government's determination to prohibit electronic cigarettes.


Each state government must take similar measures and strictly enforce the ban on electronic cigarettes and heated tobacco products.


India's Health Minister Rajesh Bhushan wrote a letter to all state and federal chief secretaries, stating that reports indicate the continued sale of e-cigarettes and related devices in convenience stores, stationery shops, and near educational institutions, making it easy for young children to access these products.


Boushang emphasized in the letter:


The supply of these prohibited products is increasing, and authorities across the country need to pay careful attention and take action to ensure effective enforcement of the 2019 "Electronic Cigarette Ban" law.


Reference:


The Centre has issued a public notice calling for stricter implementation of the law regarding violations of the vaping ban.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10